ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2845

Altered Plasticity of Inflammatory CD4 T Cells Contributing to Th17 Shift in Rheumatoid Arthritis

Jan Leipe, Fausto Pirronello, Simon Hermann, Matthias Witt, Hendrik Schulze-Koops and Alla Skapenko, Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, epigenetics and pathogenesis, Plasticity, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose
Whereas T helper (Th) cell subsets were previously regarded as irreversibly differentiated endpoints, evidence suggests that Th cell differentiation is a plastic process in response to appropriate stimulation. Mechanisms leading to the pathogenetic important predominance of Th17 cells in rheumatoid arthritis (RA) are not yet understood. We hypothesized that an altered T cell plasticity contributes to the shift towards the Th17 phenotype in RA.

Methods
A unique cohort of 35 patients with early, active and untreated RA (to exclude effects of immunosuppressive drugs on T cells) and 33 age- and sex- matched healthy controls (HC) were studied. Viable in vivo-originated Th1, Th2 and Th17 cells were FACS-sorted and trans-differentiated under Th1-, Th2- or Th17-inducing conditions. The cytokine secretion profile of the trans-differentiated cells was assessed by flow cytometry. Analysis of histone modifications in IL17 and RORC gene loci was performed by ChiP assay. The relative expression of cytokine and transcription factor genes was measured by qRT-PCR.

Results
Of interest, Th17 cells from RA patients demonstrated a strikingly diminished re-differentiation capacity into both Th1 and Th2 directions. Under Th1 conditions, RA Th17 cells retained significantly more IL-17-producing cells, whereas frequencies of newly generated Th1 cells in RA were diminished. Similarly, under Th2 conditions, frequencies of newly generated Th2 cells were significantly reduced in RA. Vice versa, RA Th1 and Th2 cells demonstrated an enhanced capacity to re-differentiate into Th17 cells. In order to analyze underlying mechanisms leading to increased re-differentiation of Th1 to Th17 cells in RA, expression of RORC was investigated. We found that RORC expression was higher after re-differentiation of Th1 cells. Moreover, in the IL17 and RORC loci an overrepresentation of the permissive histone modification H3 actetylation over the repressive H3K27 methylation was found in T cells from RA patients. Investigation of the SGK1/ FOXO1/ IL23R pathway, known to be important for Th17 stability, revealed higher expression of SGK1 and IL23R in RA after re-differentiation of sorted Th1 cells.

Conclusion
Together these data indicate that in RA in vivo-originated Th17 cells are resistant to changes in their phenotype, whereas other Th subsets are prone to Th17 cell re-differentiation. Increased RORC expression and the presence of a permissive histone modification state at the RORC gene locus might contribute to the altered Th plasticity in RA, thereby forcing Th17 cell-mediated immunity of the disease.


Disclosure:

J. Leipe,
None;

F. Pirronello,
None;

S. Hermann,
None;

M. Witt,
None;

H. Schulze-Koops,
None;

A. Skapenko,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-plasticity-of-inflammatory-cd4-t-cells-contributing-to-th17-shift-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology